Assessing very advanced HIV disease in adolescent girls and young women
| dc.contributor.author | Cassim, Naseem | |
| dc.contributor.author | Coetzee, Lindi-Marie | |
| dc.contributor.author | da Silva, Manuel P. | |
| dc.contributor.author | Glencross, Deborah K. | |
| dc.contributor.author | Stevens, Wendy S. | |
| dc.date.accessioned | 2026-06-22T09:04:27Z | |
| dc.date.issued | 2023-07 | |
| dc.description.abstract | Objectives: This study assessed very advanced HIV disease (CD4 < 100 cells/μL) in adolescent girls and young women (AGYW) in South Africa. Method: A retrospective descriptive study analysed data collated from the National Health Laboratory Service database for 2017 to 2021 calendar years for AGYW. National and provincial specimen volumes, the percentage of tests with a CD4 < 100 cells/μL and ≥ 100 cells/μL, and the median and interquartile ranges, were calculated. Logistic regression determined the odds ratio for a CD4 < 100 cells/μL, controlling for age category. Results: Data for 1 199 010 CD4 specimens indicated a significant decrease in volumes of 34% from 287 410 (2017) to 189 533 (2021). The percentage of samples with a count < 100 cells/μL ranged from 4.9% to 5.2% for YW versus 5.6% to 6.1% for AG. Provincial data for a CD4 count < 100 cells/μL ranged between 4.5% and 8.3% in AG and 3.6% to 6.3% for YW. Logistic regression indicated a 24% higher likelihood for AG having a CD4 count < 100 cells/μL. Conclusion: The study reported a higher proportion of very advanced HIV disease for AG versus YW nationally, with provincial disparity needing further analysis. | |
| dc.description.sponsorship | Wits Diagnostic Innovation Hub. | |
| dc.description.submitter | PM2026 | |
| dc.faculty | Faculty of Health Sciences | |
| dc.identifier | 0000-0003-4389-2849 | |
| dc.identifier | 0000-0002-8981-1744 | |
| dc.identifier | 0000-0001-7106-769X | |
| dc.identifier | 0009-0007-9393-5348 | |
| dc.identifier.citation | Cassim, N., Coetzee, L., da Silva, M., Glencross, D., & Stevens, W. (2023). Assessing very advanced HIV disease in adolescent girls and young women. Southern African Journal of HIV Medicine, 24(1), 8 pages. doi:https://doi.org/10.4102/sajhivmed.v24i1.1501 | |
| dc.identifier.issn | 1608-9693 (print) | |
| dc.identifier.issn | 2078-6751 (online) | |
| dc.identifier.other | 10.4102/sajhivmed.v24i1.1501 | |
| dc.identifier.uri | https://hdl.handle.net/10539/49497 | |
| dc.journal.title | Southern African Journal of HIV Medicine | |
| dc.language.iso | en | |
| dc.publisher | AOSIS Publishing | |
| dc.relation.ispartofseries | Vol. 24; Issue 1 | |
| dc.rights | © 2023. The Author(s). Licensee: AOSIS. This is an Open Access article distributed under the terms of the Creative Commons Attribution License. | |
| dc.school | School of Pathology | |
| dc.subject | HIV | |
| dc.subject | CD4 | |
| dc.subject | Immune status | |
| dc.subject | Adolescent girls | |
| dc.subject | Young women | |
| dc.subject.primarysdg | SDG-3: Good health and well-being | |
| dc.title | Assessing very advanced HIV disease in adolescent girls and young women | |
| dc.type | Article |